1. Home
  2. SRDX vs BAND Comparison

SRDX vs BAND Comparison

Compare SRDX & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • BAND
  • Stock Information
  • Founded
  • SRDX 1979
  • BAND 2000
  • Country
  • SRDX United States
  • BAND United States
  • Employees
  • SRDX N/A
  • BAND N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • BAND Computer Software: Prepackaged Software
  • Sector
  • SRDX Health Care
  • BAND Technology
  • Exchange
  • SRDX Nasdaq
  • BAND Nasdaq
  • Market Cap
  • SRDX 416.1M
  • BAND 358.3M
  • IPO Year
  • SRDX 1998
  • BAND 2017
  • Fundamental
  • Price
  • SRDX $29.00
  • BAND $13.95
  • Analyst Decision
  • SRDX Buy
  • BAND Buy
  • Analyst Count
  • SRDX 2
  • BAND 6
  • Target Price
  • SRDX $43.00
  • BAND $20.80
  • AVG Volume (30 Days)
  • SRDX 69.7K
  • BAND 250.9K
  • Earning Date
  • SRDX 07-30-2025
  • BAND 07-31-2025
  • Dividend Yield
  • SRDX N/A
  • BAND N/A
  • EPS Growth
  • SRDX N/A
  • BAND N/A
  • EPS
  • SRDX N/A
  • BAND N/A
  • Revenue
  • SRDX $121,575,000.00
  • BAND $751,695,000.00
  • Revenue This Year
  • SRDX N/A
  • BAND $2.41
  • Revenue Next Year
  • SRDX $3.70
  • BAND $13.51
  • P/E Ratio
  • SRDX N/A
  • BAND N/A
  • Revenue Growth
  • SRDX N/A
  • BAND 18.51
  • 52 Week Low
  • SRDX $26.00
  • BAND $11.33
  • 52 Week High
  • SRDX $42.44
  • BAND $23.90
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 48.86
  • BAND 47.03
  • Support Level
  • SRDX $28.67
  • BAND $13.65
  • Resistance Level
  • SRDX $29.87
  • BAND $14.37
  • Average True Range (ATR)
  • SRDX 0.75
  • BAND 0.51
  • MACD
  • SRDX -0.05
  • BAND -0.11
  • Stochastic Oscillator
  • SRDX 26.60
  • BAND 16.30

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of our revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

Share on Social Networks: